FGFR2 and breast cancer: Moderate penetrance genes have 20–50% lifetime breast cancer risk [6,7].In addition, 80 common low penetrance genes including, FGFR2 were identified by genome-wide association studies (GWAS), and smaller studies were also explained as having a 20% lifetime risk of breast cancer [8,9].